Form 4: Ironwood Pharmaceuticals Executive Sells Shares to Cover Tax Obligations

Ronald Silver, Principal Accounting Officer of Ironwood Pharmaceuticals, sold 3,107 shares of Class A Common Stock to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On August 12, 2024, Ronald Silver, the Principal Accounting Officer of Ironwood Pharmaceuticals, sold 3,107 shares of Class A Common Stock.
• The shares were sold at a price of $4.27 per share.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following the transaction, Silver directly owns 158,370 shares of Ironwood Pharmaceuticals.
• The sale was not a discretionary trade but an automatic sell-to-cover transaction to satisfy tax obligations.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (selling shares to cover taxes) and doesn't indicate any significant positive or negative sentiment.

Management Comments

• The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the Reporting Person.

Industry Context

Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. This transaction is a common practice where executives sell shares to cover tax obligations related to vesting equity.

Stakeholder Impact

• The sale of shares by an executive could have a minor negative impact on shareholder sentiment, but the reason for the sale (tax obligations) is generally understood.

Key Dates